PestleMedicine Explained

Tafluprost and timolol

Taptiqom eye drops contain tafluprost and timolol, which work together to lower the pressure in the eye. They are used in adults to treat open angle glaucoma and ocular hypertension (raised pressure within the eye).

Active ingredient: Tafluprost and timolol (1 ml of solution contains 15 micrograms of tafluprost and 5 mg of timolol)

Official leaflet

Key facts

  1. Use 1 drop in the eye or eyes, once daily, and only use it in both eyes if your doctor has told you to.
  2. Do not stop using it without asking your doctor, because the eye pressure will rise again and this may cause permanent injury to the eye.
  3. It may permanently change the colour of your iris and may change your eyelashes, the skin around the eyes and hair growth on the eyelids.
  4. It is not recommended for children and adolescents under 18 years.
  5. Blurred vision can occur, so do not drive or use machinery until you feel well and your vision is clear.

Who should not take tafluprost and timolol

The leaflet says not to take it if any of these apply to you.

  • If you are allergic to tafluprost, timolol, beta blockers or any of the other ingredients
  • If you have now or have had in the past respiratory problems such as asthma or severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/or long-standing cough)
  • If you have a slow heartbeat, heart failure or disorders of the heart rhythm (irregular heartbeats)

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • Coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking), heart failure or low blood pressure
  • Disturbances of heart rate such as slow heart beat
  • Breathing problems, asthma or chronic obstructive pulmonary disease
  • Poor blood circulation disease (such as Raynaud's disease or Raynaud's syndrome)
  • Diabetes, as timolol may mask signs and symptoms of low blood sugar
  • Overactivity of the thyroid gland, as timolol may mask signs and symptoms of thyroid disease
Show 11 moreShow fewer
  • Any allergies or anaphylactic reactions
  • Myasthenia gravis (a rare disease causing muscle weakness)
  • Other eye diseases, for example disease of the cornea or a disease requiring eye surgery
  • Kidney problems
  • Liver problems
  • Tell your doctor before an operation that you are using Taptiqom, as timolol may change the effects of some medicines used during anaesthesia
  • It may increase the length, thickness, colour and/or number of eyelashes and cause unusual hair growth on the eyelids; some of these effects may be permanent
  • It may darken the skin around the eyes; wipe off any excess solution from the skin to reduce this risk
  • It may change the colour of the iris, and if used in one eye only the treated eye may permanently become a different colour from the other eye
  • It may cause hair growth where the solution repeatedly touches the skin
  • If you have severe damage to the cornea, the phosphates in the drops may in very rare cases cause cloudy patches on the cornea due to calcium build-up

How to take tafluprost and timolol

  • Put 1 drop in the eye or eyes once daily, and only use it in both eyes if your doctor has told you to; do not use more drops or use it more often than instructed.
  • Do not let the single-dose container touch your eye or the area around it, and discard the opened container with any remaining contents straight after use.
  • After the drop, close your eye and press the inner corner of the eye with your finger for about two minutes, then wipe off any excess solution from the skin.
  • Remove contact lenses before using the drops and wait at least 15 minutes before putting them back; leave at least 5 minutes between Taptiqom and any other eye medicine.
  • If you miss a dose, use a drop as soon as you remember, unless it is nearly time for the next dose, and never use a double dose.

Side effects

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Common

Up to 1 in 10 people

  • Itching of the eye
  • Irritation in the eye
  • Eye pain
  • Redness of the eye
  • Changes in the length, thickness and number of eyelashes
  • Foreign body sensation in the eye
  • Discolouration of eyelashes
  • Sensitivity to light
  • Blurred vision

Uncommon

Up to 1 in 100 people

  • Headache
  • Dry eye
  • Redness of the eyelids
  • Small spotlike areas of inflammation on the surface of the eye
  • Watery eyes
  • Puffy eyelids
  • Tired eyes
  • Inflammation of the eyelids
  • Inflammation inside the eye
  • Discomfort in the eye
Show 3 moreShow fewer
  • Eye allergy
  • Inflammation of the eye
  • Abnormal sensation in the eye

Not stated

The leaflet gives no frequency

  • Reduction in the eye's ability to see details
  • Change of colour of the iris (may be permanent)
  • Change of colour of the skin around the eyes
  • Swelling of the eye's surface membranes
  • Eye discharge
  • Pigmentation of the eye's surface membranes
  • Follicles in the surface membranes of the eye
  • Sunken eye
  • Iritis/uveitis (inflammation of the coloured part of the eye)
  • Macular oedema/Cystoid macular oedema (swelling of the retina within the eye leading to worsening vision)
Show 59 moreShow fewer
  • Unusual hair growth on eyelids
  • Worsening of asthma
  • Shortness of breath
  • Allergic reactions, including swelling beneath the skin, hives, rash
  • Severe sudden life-threatening allergic reaction
  • Itching
  • Low blood sugar
  • Depression
  • Difficulty sleeping
  • Nightmares
  • Memory loss
  • Nervousness
  • Hallucination
  • Dizziness
  • Fainting
  • Unusual sensations (like pins and needles)
  • Increases in signs and symptoms of myasthenia gravis (muscle disorder)
  • Stroke
  • Reduced blood supply to the brain
  • Inflammation of the cornea
  • Decreased corneal sensitivity
  • Visual disturbances including refractive changes (sometimes due to withdrawal of miotic therapy)
  • Drooping of the upper eyelid
  • Double vision
  • Blurred vision and detachment of the layer below the retina that contains blood-vessels following filtration surgery which may cause visual disturbances
  • Corneal erosion
  • Tinnitus (ringing in the ears)
  • Slow heart rate
  • Chest pain
  • Palpitations
  • Oedema (fluid build-up)
  • Changes in the rhythm or speed of the heartbeat
  • Congestive heart failure (heart disease with shortness of breath and swelling of the feet and legs due to fluid build-up)
  • A type of heart rhythm disorder
  • Heart attack
  • Heart failure
  • Low blood pressure
  • Limping
  • Raynaud's phenomenon, cold hands and feet
  • Constriction of the airways in the lungs (predominantly in patients with pre-existing disease)
  • Difficulty breathing
  • Cough
  • Nausea
  • Indigestion
  • Diarrhoea
  • Dry mouth
  • Taste disturbances
  • Abdominal pain
  • Vomiting
  • Hair loss
  • Skin rash with white silvery-coloured appearance (psoriasiform rash) or worsening of psoriasis
  • Skin rash
  • Muscle pain not caused by exercise
  • Joint pain
  • Peyronie's disease (which may cause a curvature of the penis)
  • Sexual dysfunction
  • Decreased libido
  • Muscle weakness/tiredness
  • Thirst

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

Do not use Taptiqom if you are pregnant, and if you may become pregnant you must use an effective method of birth control during treatment. You should not use it if you are breast-feeding; ask your doctor for advice.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • Other eye drops for the treatment of glaucoma
  • Medicines to lower blood pressure
  • Heart medicine
  • Medicines to treat diabetes
  • Quinidine (used to treat heart conditions and some types of malaria)
  • Antidepressants known as fluoxetine and paroxetine

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Taptiqom 15 micrograms/ml + 5 mg/ml Eye Drops Solution In Single-Dose Container
Product licence
PL 16058/0012
Leaflet dated
Checked against the leaflet
Automated check
91 of 91 side effects matched to the wording of the leaflet

Other makers of tafluprost and timolol publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.